KEGG: ypo:BZ17_2160
SugE (Suppressor of groEL mutation) is a small membrane protein that belongs to the Small Multidrug Resistance (SMR) family. Initially identified as a suppressor of groEL mutations in Escherichia coli, SugE has been definitively shown to confer resistance to a specific subset of quaternary ammonium compounds (QACs). Unlike other members of the SMR family that typically have broader substrate specificities, SugE exhibits a remarkably narrow specificity profile, conferring resistance primarily to specific antiseptic QACs including cetylpyridinium chloride, cetylpyridinium bromide, cetyldimethylethyl ammonium bromide, and hexadecyltrimethyl ammonium bromide (cetrimide) .
The protein consists of approximately 110 amino acids and contains four transmembrane segments. SugE can function either as a homo- or heterodimeric system to facilitate the export of toxic QACs from bacterial cells, thereby conferring resistance to these compounds .
SugE differs from other quaternary ammonium compound resistance proteins in several key aspects:
Substrate Specificity: SugE exhibits an unusually narrow substrate specificity compared to other SMR family members. While proteins like EmrE confer resistance to a broad range of compounds, SugE specifically targets a limited subset of quaternary ammonium antiseptics .
Resistance Profile: SugE does not confer resistance to many compounds that are substrates for other SMR proteins, including cationic dyes (tetraphenyl-arsonium chloride, pyronine Y, crystal violet, ethidium bromide) and certain QACs (benzyl-dimethyl tetradecylammonium chloride, benzalkonium chloride) .
Genetic Context: Unlike qacE and qacEΔ1, which are often associated with class 1 integrons and the sul1 gene, sugE genes may be found in different genetic contexts, including both chromosomal (sugE(c)) and plasmid (sugE(p)) variants .
This unique resistance profile distinguishes SugE as a specialized QAC resistance determinant within the broader family of multidrug resistance proteins.
Based on successful experimental approaches documented in the literature, the following expression systems have proven effective for studying SugE function:
pBAD24 Expression Vector: This arabinose-inducible expression system allows for controlled expression of the sugE gene. The gene can be cloned into the polylinker region of pBAD24 using appropriate restriction enzymes (e.g., EcoRI and PstI). Expression can be maintained at low (basal) levels in the absence of L-arabinose or induced to high levels with 0.2% L-arabinose, although high-level expression may prove toxic to cells .
pCR2.1 Vector System: The sugE gene can be amplified by PCR with appropriate primers and directly cloned into the pCR2.1 TOPO vector. Including approximately 134 bp of the upstream promoter region allows for native regulation of sugE expression. This approach has successfully demonstrated SugE-mediated resistance in multiple E. coli strains, including DH5α, TOP10F′, and ABLE-C .
When designing your expression system, consider the orientation of the inserted gene relative to promoters on the vector and verify your constructs through both restriction enzyme digestion and direct sequencing to ensure proper insertion and sequence integrity .
To effectively measure QAC resistance conferred by SugE, consider the following methodological approach:
Minimum Inhibitory Concentration (MIC) Determination:
Prepare LB agar plates containing various concentrations of QACs (doubling dilutions)
Compare growth of strains expressing sugE with control strains (carrying empty vectors)
Determine the MIC values for each compound tested
Recommended Test Compounds:
Cetylpyridinium chloride (C₂₁H₃₈NCl)
Cetylpyridinium bromide (C₂₁H₃₈NBr)
Cetyldimethylethyl ammonium bromide (C₂₀H₄₂NBr)
Hexadecyltrimethyl ammonium bromide (cetrimide) (C₁₉H₄₂NBr)
Control Compounds (where no resistance is expected):
Benzyl-dimethyl tetradecylammonium chloride
Benzalkonium chloride
Cationic dyes (tetraphenyl-arsonium chloride, pyronine Y, crystal violet, ethidium bromide)
Table 1 below illustrates the typical MIC values observed in a well-designed experiment:
| Compound | MIC (μg/ml) for Control Strain | MIC (μg/ml) for SugE-expressing Strain | Fold Increase |
|---|---|---|---|
| Cetylpyridinium chloride | 20 | 160 | 8× |
| Cetylpyridinium bromide | 40 | 160-180 | 4-4.5× |
| Cetyldimethylethyl ammonium bromide | 60 | 120 | 2× |
| Hexadecyltrimethyl ammonium bromide | 60-80 | 120 | 1.5-2× |
Remember that media composition (complex versus minimal) has minimal effect on the resistance phenotype, but the host strain should be carefully selected based on experimental objectives .
To comprehensively analyze the genetic context of sugE, consider the following methodological approaches:
PCR-Based Analysis:
Design primers targeting sugE and its flanking regions
Use PCR "primer-walking" strategy with overlapping fragments to determine complete genetic arrangement
Sequence obtained amplicons on both strands for verification
Plasmid Analysis (for plasmid-borne sugE variants):
Isolate plasmid DNA using appropriate extraction kits
Determine plasmid number and size using S1 nuclease digestion followed by PFGE
Perform Southern blot hybridization with DIG-labeled probes specific to sugE
Integration with Other Resistance Genes:
These approaches will help establish whether sugE is chromosomal or plasmid-borne, its association with mobile genetic elements, and potential co-localization with other resistance determinants.
Differentiating between chromosomal sugE(c) and plasmid-borne sugE(p) variants requires a systematic approach combining molecular and genetic techniques:
Genomic vs. Plasmid DNA Extraction:
Perform separate extractions of genomic and plasmid DNA
Screen both fractions for sugE using PCR with specific primers
S1-PFGE Analysis:
Sequence Analysis and Comparison:
Sequence the amplified sugE genes
Compare with known sugE(c) and sugE(p) sequences for nucleotide and amino acid variations
Analyze flanking regions for characteristic features of chromosomal vs. plasmid contexts
Conjugation Experiments:
The combined results of these approaches will provide robust evidence for the classification of sugE variants as either chromosomal or plasmid-borne.
Investigating structure-function relationships in SugE requires sophisticated methodological approaches:
Site-Directed Mutagenesis:
Target conserved amino acid residues based on sequence alignments with other SMR family proteins
Focus particularly on the fully conserved glutamate residue essential for EmrE function
Create single and multiple amino acid substitutions
Evaluate mutants for altered resistance profiles and substrate specificities
Membrane Protein Structural Analysis:
Express and purify recombinant SugE protein
Perform X-ray crystallography or cryo-electron microscopy for high-resolution structural determination
Use NMR spectroscopy for dynamic structural information
Apply computational modeling to predict structural features and substrate binding
Substrate Binding Studies:
Conduct isothermal titration calorimetry (ITC) experiments with purified SugE and QAC substrates
Perform fluorescence-based binding assays
Use surface plasmon resonance (SPR) to measure binding kinetics and affinities
Transport Assays:
Reconstitute SugE in proteoliposomes
Measure substrate transport using fluorescent probes or radiolabeled compounds
Monitor proton/substrate exchange to elucidate the mechanistic basis of transport
These approaches will provide comprehensive insights into the structural determinants of SugE specificity and the molecular mechanisms underlying its resistance function.
Determining the oligomeric state of SugE requires a multi-faceted experimental approach:
Cross-linking Studies:
Treat SugE-expressing cells or purified protein with chemical cross-linkers
Analyze by SDS-PAGE to detect higher molecular weight species
Compare molecular weights with theoretical predictions for monomers, homodimers, or heterodimers
Co-immunoprecipitation:
Create differentially tagged versions of SugE (e.g., His-tagged and FLAG-tagged)
Co-express in bacterial cells
Perform immunoprecipitation with one tag and detect the presence of the other tag
Positive results would indicate formation of homodimers
FRET Analysis:
Generate SugE fusion proteins with compatible fluorophores (e.g., CFP and YFP)
Co-express and measure Förster resonance energy transfer
Quantify FRET efficiency as a measure of protein-protein interaction
Bacterial Two-Hybrid System:
Clone sugE into bacterial two-hybrid vectors
Test for self-interaction (homodimerization)
Test for interaction with other potential partner proteins (heterodimerization)
The evidence from SMR family proteins suggests that SugE likely functions as a homodimer, similar to other characterized members of this family that exhibit four transmembrane segments and function as either homo- or heterodimeric systems .
SugE represents a distinct evolutionary branch within the SMR family with specialized functional characteristics:
Phylogenetic Positioning:
SugE belongs to the SugE subfamily within the broader SMR family
This subfamily is distinct from the better-characterized EmrE subfamily
SugE proteins from gram-negative and gram-positive bacteria form a coherent phylogenetic group
Functional Divergence:
Unlike EmrE and other SMR proteins with broad substrate ranges, SugE exhibits narrow substrate specificity
This specialization suggests functional divergence during evolution
The resistance profile of SugE (limited to specific QACs) contrasts with the broader multidrug resistance of other SMR proteins
Conservation vs. Specialization:
SugE maintains the core structural features of SMR proteins (four transmembrane segments, ~110 amino acids)
Key functional residues may be conserved between subfamilies
Substrate binding pocket residues likely diverged to create specificity differences
Experimental Approaches to Evolutionary Studies:
Perform comprehensive sequence alignments of SugE homologs across bacterial species
Conduct selection pressure analysis to identify positively selected residues
Use ancestral sequence reconstruction to infer evolutionary trajectory
Compare substrate specificities of SugE orthologs from diverse bacterial species
This evolutionary context provides a framework for understanding the specialized role of SugE in QAC resistance and its divergence from other SMR family transporters.
When investigating SugE orthologs across bacterial species, consider the following methodological approach:
Identification and Cloning Strategy:
Use bioinformatic tools to identify putative SugE orthologs
Design degenerate primers based on conserved regions
Employ touchdown PCR to accommodate sequence variations
Consider codon optimization when expressing orthologs in heterologous systems
Expression System Selection:
Choose expression systems compatible with the codon usage of the source organism
Consider using the native promoter or a well-characterized heterologous promoter
Verify protein expression through Western blotting or fluorescent tagging
Comparative Resistance Profiling:
Test each ortholog against the same panel of QACs under standardized conditions
Include the E. coli SugE as a reference point
Generate comprehensive MIC data tables for comparison
Consider testing additional compounds beyond the established SugE substrates
Functional Complementation:
Express SugE orthologs in E. coli strains lacking endogenous sugE
Assess their ability to confer resistance to QACs
Compare complementation efficiency across orthologs
This systematic approach will illuminate the functional conservation or divergence of SugE proteins across bacterial species and provide insights into the evolution of QAC resistance mechanisms.